
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Intrinsic Value
The intrinsic value of one
Zylox-Tonbridge Medical Technology Co Ltd
stock under the Base Case scenario is
14.51
HKD.
Compared to the current market price of 16.8 HKD,
Zylox-Tonbridge Medical Technology Co Ltd
is
Overvalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Zylox-Tonbridge Medical Technology Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Zylox-Tonbridge Medical Technology Co Ltd
Balance Sheet Decomposition
Zylox-Tonbridge Medical Technology Co Ltd
Current Assets | 1.4B |
Cash & Short-Term Investments | 1.2B |
Receivables | 16.2m |
Other Current Assets | 193.6m |
Non-Current Assets | 2.1B |
Long-Term Investments | 1.4B |
PP&E | 655m |
Intangibles | 34.7m |
Other Non-Current Assets | 3m |
Free Cash Flow Analysis
Zylox-Tonbridge Medical Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Zylox-Tonbridge Medical Technology Co Ltd
Revenue
|
782.5m
CNY
|
Cost of Revenue
|
-222.6m
CNY
|
Gross Profit
|
559.9m
CNY
|
Operating Expenses
|
-523.7m
CNY
|
Operating Income
|
36.2m
CNY
|
Other Expenses
|
64m
CNY
|
Net Income
|
100.3m
CNY
|
Profitability Score
Profitability Due Diligence
Zylox-Tonbridge Medical Technology Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Score
Zylox-Tonbridge Medical Technology Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zylox-Tonbridge Medical Technology Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Score
Zylox-Tonbridge Medical Technology Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zylox-Tonbridge Medical Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Zylox-Tonbridge Medical Technology Co Ltd
is 19.18 HKD
with a low forecast of 18.79 HKD and a high forecast of 19.95 HKD.
Dividends
Current shareholder yield for Zylox-Tonbridge Medical Technology Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Zylox-Tonbridge Medical Technology Co Ltd
stock under the Base Case scenario is
14.51
HKD.
Compared to the current market price of 16.8 HKD,
Zylox-Tonbridge Medical Technology Co Ltd
is
Overvalued by 14%.